Gsp Pharmaceuiticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.07 M
- Revenue Growth -64.37%
- Profit Growth 31.40%
- Ebitda 32.19%
- Net Worth -51.58%
- Total Assets -14.41%
About Gsp Pharmaceuiticals
Gsp Pharmaceuiticals Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 April 2013 and has a history of 11 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Spgmr Technologies Private Limited. The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.07 M.
Padmasree Gorla and Poornima Gorla serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U93030TG2013PTC086982
- Company No.
086982
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Gsp Pharmaceuiticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padmasree Gorla  | Director | 12-Mar-2020 | Current |
| Poornima Gorla | Additional Director | 12-Mar-2020 | Current |
Financial Performance of Gsp Pharmaceuiticals.
Gsp Pharmaceuiticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 64.37% decrease. The company also saw a substantial improvement in profitability, with a 31.4% increase in profit. The company's net worth observed a substantial decline by a decrease of 51.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gsp Pharmaceuiticals?
In 2018, Gsp Pharmaceuiticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saigmr Constructions Private LimitedPoornima Gorla is a mutual person
- Gaganasai International Private Limited
Poornima Gorla is a mutual person
- Sgmr Pharmaceuiticals Private Limited
Poornima Gorla is a mutual person
Charges (Loans)
₹1.07 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2021 | Hdfc Bank Limited | ₹1.07 M | Open |
How Many Employees Work at Gsp Pharmaceuiticals?
Unlock and access historical data on people associated with Gsp Pharmaceuiticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gsp Pharmaceuiticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gsp Pharmaceuiticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
